Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor

Molecular and Cellular Biology

Volumn 32, Issue 21, 2012, Pages 4419-4431

  Lucki, Natasha C ^a   Li, Donghui ^a   Bandyopadhyay, Sibali ^b   Wang, Elaine ^b   Merrill, Alfred H ^b   Sewer, Marion B ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CERAMIDASE; CYCLIC AMP; SPHINGOLIPID;

ADRENAL CORTEX CELL; ARTICLE; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYP17A1 GENE; GENE; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPID METABOLISM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; REPORTER GENE; SIGNAL TRANSDUCTION; STEROIDOGENIC ACUTE REGULATORY PROTEIN GENE; STEROIDOGENIC FACTOR 1 GENE;

ACID CERAMIDASE; ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELL LINE; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CYCLIC AMP; DNA-BINDING PROTEINS; HAPLORHINI; HUMANS; LIPID METABOLISM; MICE; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOSINE; STEROID 17-ALPHA-HYDROXYLASE; STEROIDOGENIC FACTOR 1; TRANSCRIPTION, GENETIC;

EID: 84868711153     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00378-12     Document Type: Article

References (82)

1. Albi E, Magni MP. 1997. Chromatin neutral sphingomyelinase and its role in hepatic regeneration. Biochem. Biophys. Res. Commun. 236: 29 -33.
2. Albi E, Magni MV. 1999. Sphingomyelin synthase in rat liver nuclear membrane and chromatin. FEBS Lett. 460:369 -372.
3. Bernardo K, et al. 1995. Purification, characterization, and biosynthesis of human acid ceramidase. J. Biol. Chem. 270:11098 -11102.
4. Blind RD, Suzawa M, Ingraham HA. 2012. Direct modification and activation of a nuclear receptor-PIP2 complex by the inositol lipid kinase IPMK. Sci. Signal. 5:ra44. doi:10.1126/scisignal.2003111.
5. Børud B, et al. 2002. The nuclear receptor coactivators p300/CBP/ cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol. Endocrinol. 16:757-773.
6. Chen WY, Juan LJ, Chung BC. 2005. SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via p300-mediated recruitment to active foci, acetylation, and increasedDNAbinding. Mol. Cell. Biol. 25:10442-10453.
7. Chen WY, Lee WC, Hsu NC, Huang F, Chung BC. 2004. SUMO modification of repression domains modulates function of nuclear receptor 5A1 (steroidogenic factor-1). J. Biol. Chem. 279:38730 -38735.
8. Chuderland D, Konson A, Seger R. 2008. Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol. Cell 31:850-861.
9. Crawford PA, Dorn C, Sadovsky Y, Milbrandt J. 1998. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell. Biol. 18:2949 -2956.
10. Crawford PA, Polish JA, Ganpule G, Sadovsky Y. 1997. The activation function-2 hexamer of steroidogenic factor-1 is required, but not sufficient for potentiation by SRC-1. Mol. Endocrinol. 11:1626 -1635.
11. Cuvillier O. 2002. Sphingosine in apoptosis signaling. Biochim. Biophys. Acta 1585:153-162.
12. Dammer EB, Leon A, Sewer MB. 2007. Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3',5'-monophosphate-dependent cytochrome P450c17 transcription rate. Mol. Endocrinol. 21:415- 438.
13. Desclozeaux M, Krylova IN, Horn F, Fletterick RJ, Ingraham HA. 2002. Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol. Cell. Biol. 22:7193-7203.
14. Dubbink HJ, et al. 2006. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Mol. Endocrinol. 20:1742-1755.
15. Duverger E, Pellerin-Mendes C, Mayer R, Roche AC, Monsigny M. 1995. Nuclear import of glycoconjugates is distinct from the classical NLS pathway. J. Cell Sci. 108(Part 4):1325-1332.
16. Eliyahu E, Park JH, Shtraizent N, He X, Schuchman EH. 2007. Acid ceramidase is a novel factor required for early embryo survival. FASEB J. 21:1403-1409.
17. Ferlinz K, et al. 2001. Human acid ceramidase: processing, glycosylation, and lysosomal targeting. J. Biol. Chem. 276:35352-35360.
18. Glass CK, Rosenfeld MG. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-141.
19. Görlich D. 1997. Nuclear protein import. Curr. Opin. Cell Biol. 9:412- 419.
20. Hait NC, et al. 2009. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325:1254 -1257.
21. Hammer GD, et al. 1999. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol. Cell 3:521-526.
22. Heery DM, Kalkhoven E, Hoare S, Parker MG. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736.
23. Heldring N, et al. 2007. Structural insights into corepressor recognition by antagonist-bound estrogen receptors. J. Biol. Chem. 282:10449 -10455.
24. Hsia EY, Goodson ML, Zou JX, Privalsky ML, Chen HW. 2010. Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv. Drug Deliv. Rev. 62:1227-1237.
25. Hu X, Lazar MA. 1999. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402:93-96.
26. Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K. 2000. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta 1485:63-99.
27. Ishihara SL, Morohashi K. 2005. A boundary for histone acetylation allows distinct expression patterns of the Ad4BP/SF-1 and GCNF loci in adrenal cortex cells. Biochem. Biophys. Res. Commun. 329:554 -562.
28. Ito M, Yu R, Jameson JL. 1997. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17:1476 -1483.
29. Ito M, Yu RN, Jameson JL. 1998. Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol. Endocrinol. 12:290 -301.
30. Jacob AL, Lund J, Martinez P, Hedin L. 2001. Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. J. Biol. Chem. 276:37659 -37664.
31. Komatsu T, et al. 2004. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/ steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol. Endocrinol. 18:2451-2462.
32. Krylova IN, et al. 2005. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343- 355.
33. Kumar R, Gururaj AE, Vadlamudi RK, Rayala SK. 2005. The clinical relevance of steroid hormone receptor corepressors. Clin. Cancer Res. 11:2822-2831.
34. Lala DS, Rice DA, Parker KL. 1992. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol. Endocrinol. 6:1249 -1258.
35. Ledeen RW, Wu G. 2008. Nuclear sphingolipids: metabolism and signaling. J. Lipid Res. 49:1176 -1186.
36. Li D, et al. 2007. Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase Θ facilitates induction of CYP17. Mol. Cell. Biol. 27:6669-6685.
37. Li LA, et al. 1999. Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun. Mol. Endocrinol. 13:1588 -1598.
38. Li Y, et al. 2005. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol. Cell 17:491-502.
39. Linke T, et al. 2001. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins. J. Biol. Chem. 276:5760 -5768.
40. Lucki N, Sewer MB. 2009. The cAMP-responsive element binding protein (CREB) regulates the expression of acid ceramidase (ASAH1) in H295R human adrenocortical cells. Biochim. Biophys. Acta 1791:706- 713.
41. Lucki NC, Bandyopadhyay S, Wang E, Merrill AH, Sewer MB. 2012. Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression. Mol. Endocrinol. 26:228 -243.
42. Lucki NC, Sewer MB. 2008. Multiple roles for sphingolipids in steroid hormone biosynthesis. Subcell. Biochem. 49:387- 412.
43. Mangelsdorf DJ, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835- 839.
44. McInerney EM, et al. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12: 3357-3368.
45. Monté D, DeWitte F, Hum DW. 1998. Regulation of the human P450scc gene by steroidogenic factor 1 is mediated by CBP/p300. J. Biol. Chem. 273:4585- 4591.
46. Neitcheva T, Peeva D. 1995. Phospholipid composition, phospholipase A2 and sphingomyelinase activities in rat liver nuclear membrane and matrix. Int. J. Biochem. Cell Biol. 27:995-1001.
47. Ozbay T, Merrill AH, Jr, Sewer MB. 2004. ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via sphingolipid metabolism. Endocr. Res. 30:787-794.
48. Ozbay T, Rowan A, Leon A, Patel P, Sewer MB. 2006. Cyclic adenosine 5'-monophosphate-dependent sphingosine-1-phosphate biosynthesis induces human CYP17 gene transcription by activating cleavage of sterol regulatory element binding protein 1. Endocrinology 147:1427-1437.
49. Park J, Schuchuman E. 2006. Acid ceramidase and human disease. Biochim. Biophys. Acta 1758:2133-2138.
50. Parker KL, et al. 2002. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog. Horm. Res. 57:19 -36.
51. Payne AH, Hales DB. 2004. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25: 947-970.
52. Perissi V, et al. 1999. Molecular determinants of nuclear receptorcorepressor interaction. Genes Dev. 13:3198 -3208.
53. Pettus BJ, Chalfant CE, Hannun YA. 2002. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585:114 -125.
54. Plotnikov A, Chuderland D, Karamansha Y, Livnah O, Seger R. 2011. Nuclear extracellular signal-regulated kinase 1 and 2 translocation is mediated by casein kinase 2 and accelerated by autophosphorylation. Mol. Cell. Biol. 31:3515-3530.
55. Rainey WE, Bird IM, Mason JI. 1994. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol. Cell. Endocrinol. 100:45-50.
56. Romiti E, et al. 2000. Neutral/alkaline and acid ceramidase activities are actively released by murine endothelial cells. Biochem. Biophys. Res. Commun. 275:746 -751.
57. Rosenfeld MG, Lunyak VV, Glass CK. 2006. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20:1405-1428.
58. Sablin EP, et al. 2009. Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. Mol. Endocrinol. 23:25-34.
59. Sakane F, Yamada K, Kanoh H. 1989. Different effects of sphingosine, R59022 and anionic amphiphiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol. FEBS Lett. 255:409-413.
60. Selzner M, et al. 2001. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 61:1233-1240.
61. Sewer MB, et al. 2002. Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription. Endocrinology 143: 1280-1290.
62. Sewer MB, Waterman MR. 2003. ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc. Res. Tech. 61:300 -307.
63. Sewer MB, Waterman MR. 2002. Adrenocorticotropin/cyclic adenosine 3',5'-monophosphate-mediated transcription of the human CYP17 gene in the adrenal cortex is dependent on phosphatase activity. Endocrinology 143:1769 -1777.
64. Sewer MB, Waterman MR. 2002. cAMP-dependent transcription of steroidogenic genes in the human adrenal cortex requires a dual-specificity phosphatase in addition to protein kinase A. J. Mol. Endocrinol. 29:163- 174.
65. Shao D, et al. 1998. Interdomain communication regulating ligand binding by PPAR-gamma. Nature 396:377-380.
66. Shtraizent N, et al. 2008. Autoproteolytic cleavage and activation of human acid ceramidase. J. Biol. Chem. 283:11253-11259.
67. Spiegel S, Milstien S. 2002. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277:25851-25854.
68. Staels B, Hum DW, Miller WL. 1993. Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. Mol. Endocrinol. 7:423- 433.
69. Sullards MC. 2000. Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. Methods Enzymol. 312:32- 45.
70. Sullards MC, Merrill AH, Jr. 2001. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci. STKE 2001:pl1.
71. Suzuki T, Kasahara M, Yoshioka H, Morohashi K, Umesono K. 2003. LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Mol. Cell. Biol. 23:238 -249.
72. Tamiya-Koizumi K, Umekawa H, Yoshida S, Kojima K. 1989. Existence of Mg2 -dependent, neutral sphingomyelinase in nuclei of rat ascites hepatoma cells. J. Biochem. 106:593-598.
73. Tremblay A, Tremblay GB, Labrie F, Giguere V. 1999. Ligandindependent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol. Cell 3:513-519.
74. Urs AN, et al. 2007. Steroidogenic factor-1 is a sphingolipid binding protein. Mol. Cell. Endocrinol. 265-266:174 -178.
75. Urs AN, Dammer E, Sewer M. 2006. Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. Endocrinology 147: 5249-5258.
76. Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH, Jr. 1991. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266: 14486-14490.
77. Wang W, et al. 2005. The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc. Natl. Acad. Sci. U. S. A. 102:7505-7510.
78. Wattenberg BW, Pitson SM, Raben DM. 2006. The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. J. Lipid Res. 47:1128 -1139.
79. Winnay JN, Hammer GD. 2006. Adrenocorticotropic hormonemediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation. Mol. Endocrinol. 20:147- 166.
80. Yazawa T, et al. 2010. PPAR-gamma coactivator-1alpha regulates progesterone production in ovarian granulosa cells with SF-1 and LRH-1. Mol. Endocrinol. 24:485- 496.
81. Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. 2000. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J. Biol. Chem. 275:39855-39859.
82. Zhou D, et al. 2000. PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors, including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1). Mol. Endocrinol. 14:986- 998.